首页> 外文OA文献 >Correction to: Mono vs. combo regimens with novel beta-lactam/beta-lactamase inhibitor combinations for the treatment of infections due to carbapenemase-producing Enterobacterales: insights from the literature

【2h】

Correction to: Mono vs. combo regimens with novel beta-lactam/beta-lactamase inhibitor combinations for the treatment of infections due to carbapenemase-producing Enterobacterales: insights from the literature

机译：校正：Mono与组合中具有新型β-内酰胺/β-内酰胺酶抑制剂组合的组合，用于治疗碳碱酶的肠杆菌引起的感染：来自文献的见解

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Simone Meini; Bruno Viaggi; Carlo Tascini;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The latest advances in beta-lactam/beta-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections [J] . Papp-Wallace Krisztina M. Expert opinion on pharmacotherapy . 2019,第13a18期

机译：β-内酰胺/β-内酰胺酶抑制剂组合的最新进展，用于治疗革兰氏阴性细菌感染
2. A Multinational, Preregistered Cohort Study of beta-Lactam/beta-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-beta-Lactamase-Producing Enterobacteriaceae [J] . Gutierrez-Gutierrez Belen, Perez-Galera Salvador, Salamanca Elena, Antimicrobial agents and chemotherapy. . 2016,第7期

机译：β-内酰胺/β-内酰胺酶抑制剂组合的多国，预注册队列研究，用于治疗因产生广谱β-内酰胺酶的肠杆菌科引起的血流感染
3. Ceftolozane/tazobactam and ceftazidime/avibactam: two novel beta-lactam/beta-lactamase inhibitor combination agents for the treatment of resistant Gram-negative bacterial infections [J] . Liscio Jordan L., Mahoney Monica V., Hirsch Elizabeth B. International journal of antimicrobial agents . 2015,第3期

机译：头孢唑烷/他唑巴坦和头孢他啶/ avibactam：两种新型的β-内酰胺/β-内酰胺酶抑制剂组合剂，用于治疗耐药革兰氏阴性细菌感染
4. Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections [O] . Tanaya Bhowmick, Melvin P. Weinstein 2020

机译：Meropenem-Vabbordam的微生物学：一种新的Carbapenemβ-内酰胺酶抑制剂组合用于耐肠道肠杆菌感染
5. A multinational, preregistered cohort study of beta-lactam/beta-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-beta-lactamase-producing Enterobacteriaceae [O] . Gutierrez-Gutierrez, Belen, Perez-Galera, Salvador, Salamanca, Elena, 2016

机译：一项针对β-内酰胺/β-内酰胺酶抑制剂组合的跨国预注册队列研究，用于治疗因产生广谱β-内酰胺酶的肠杆菌科引起的血流感染

Correction to: Mono vs. combo regimens with novel beta-lactam/beta-lactamase inhibitor combinations for the treatment of infections due to carbapenemase-producing Enterobacterales: insights from the literature

著录项

引文网络

相似文献

相关主题

期刊订阅